Latin American Patients With Diabetes Prefer SGLT2 Inhibitors Latin American Patients With Diabetes Prefer SGLT2 Inhibitors
Findings from a recent study highlight the need for clear discussions between patients and physicians before defining a treatment strategy.Medscape Medical News
Source: Medscape Internal Medicine Headlines - Category: Internal Medicine Tags: Diabetes & Endocrinology News Source Type: news